30 Years of Groundbreaking Science, Training, and Innovation

Satellite Programs

Interventional Therapies for Hypertension: Current Evidence and Controversies

Breakfast Program

09/24/2018 07:00:00 09/24/2018 08:00:00 Interventional Therapies for Hypertension: Current Evidence and Controversies TCT 2017 true MM/DD/YYYY TCT 2014 Satellite Symposia - Breakfast Program

Monday, September 24, 2018
Breakfast: 6:30 am  | 
Program: 7:00 am-8:00 am
San Diego, CA, 23B-C

Interventional Therapies for Hypertension: Current Evidence and Controversies

Interventional Therapies for Hypertension: Current Evidence and Controversies

Sponsored by Cardiovascular Research Foundation

Supported through an educational grant from Medtronic

The Cardiovascular Research Foundation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Cardiovascular Research Foundation designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Chairs  

Juan F. Granada, MD

Cardiovascular Research Foundation

New York, NY

 

Ajay J. Kirtane, MD, SM

NewYork-Presbyterian/Columbia University Medical Center

New York, USA

 

Martin B. Leon, MD

NewYork-Presbyterian/Columbia University Medical Center

New York, NY

Faculty  

David E. Kandzari, MD

Piedmont Heart Institute

Atlanta, GA

 

Felix Mahfoud, MD

Saarland University Medical Center

Homburg/Saarland, Germany

 

Michael A. Weber, MD

SUNY Downstate Medical Center

Brooklyn, NY

Agenda

7:00 am

Welcome and Introductions

Martin B. Leon

7:02 am

Preclinical Advances in the Understanding of Interventional Hypertension Therapies

Felix Mahfoud

7:14 am

Moderated Discussion

7:19 am

In Case You Missed It: What’s Happened (So Very) Recently in Renal Denervation

Ajay J. Kirtane

7:31 am

On Meds or Off Meds: What is the Sweet Spot for Device-Based Hypertension Therapies?

Michael A. Weber

7:42 am

Regulatory and Reimbursement Challenges for Hypertension Therapies: My Crystal Ball for the Next 5-10 years

David E. Kandzari

7:54 am

Moderated Discussion

8:00 am

Adjourn